FDA clears FloPump 32 from International Biophysics

International Biophysics said today that it won 510(k) clearance from the FDA for its FloPump 32 centrifugal disposable heart pump, designed for use with Getinge (PINK:GETI B) subsidiary Maquet Cardiovascular‘s RotaFlow console.
Austin, Texas-based International Biophysics tout The FloPump 32 as one of the smallest centrifugal pumps in the world at 32ml prime.
“With this FDA clearance of our FloPump 32 for the U.S. market we continue to bring the highest quality surgical products to the market while lowering healthcare costs,” founder & CEO David Shockley said in prepared remarks. “We launched the FloPump 32 internationally to strong demand in 2017 when we received both the CE Mark for Europe and ANVISA for the Brazilian market. We anticipate the same strong demand here in the U.S now that we have been cleared for this market too.”
The company said it tapped Austin’s Origen Biomedical as the sole U.S. distributor of the device and plans to use that firm to distribute in Canada after an expected nod from Health Canada comes through early next year.
“We are very pleased with the FDA declaration of substantial equivalence on the FloPump 32. We believe that the release of this device in the United States will give wider availability and more options to institutions using Rotaflow hardware,” added Origen founder & CEO Richard Martin.
The post FDA clears FloPump 32 from International Biophysics appeared first on MassDevic...

Source: Mass Device - January 17, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Cardiac Assist Devices Food & Drug Administration (FDA) Regulatory/Compliance Getinge internationalbiophysics Maquet Cardiovascular LLC Origen Biomedical Source Type: news